Procter & Gamble Health Ltd - P & G HEALTH LTD Share Price

Sector: Pharmaceuticals | ISIN: INE199A01012
₹ 4,671.65 (-0.61%) icon19 Apr, 2024, 10:09:58 AM

Procter & Gamble Health Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/19/2024 10:09:58 AM

    ₹ 4671.65 -28.85 -0.61
  • Open
  • ₹ 4,675
  • Prev. Close
  • ₹ 4,700.5
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 4,686
  • Day's Low
  • ₹ 4,642.55
  • 52 Week's High
  • ₹ 5,642.85
  • 52 Week's Low
  • ₹ 4,575
  • Book Value
  • ₹ 535.26
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 7,754.94
  • P/E
  • 34.37
  • EPS
  • 136.54
  • Divi. Yield
  • 1.31

Procter & Gamble Health Ltd Corporate Actions

06 Feb , 2024

12:00 AM

Dividend

Dividend amount: 50
Announcement date: 06 Feb , 2024

View Details

06 Feb , 2024

12:00 AM

Dividend

Dividend amount: 150
Announcement date: 06 Feb , 2024

View Details

12 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Jan , 2024

12:00 AM

24 Aug , 2023

12:00 AM

AGM

Announcement date: 24 Aug , 2023

View Details

23 Aug , 2023

12:00 AM

Dividend

Dividend amount: 50
Announcement date: 23 Aug , 2023

View Details

27 Sep , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Sep , 2023

12:00 AM

17 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Apr , 2023

12:00 AM

24 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Procter & Gamble Health Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Procter & Gamble Health Ltd SHAREHOLDING SNAPSHOT
19 April , 2024 | 10:26 AM

PROMOTER - TOTAL51.82%

Indian: 0.00%

Foreign: 51.8156%

NON-PROMOTER - TOTAL 48.18%

Institutions: 19.97%

Non-Institutions: 28.21%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Procter & Gamble Health Ltd FINANCIALS

No Data Available To Display Chart

Procter & Gamble Health Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Procter & Gamble Health Ltd

  • S N Talwar
  • Chairman & Independent Directo
  • Rani A Jadhav
  • Independent Director
  • Milind Thatte
  • Managing Director
  • Amit Gupta
  • Director (Finance) & CFO
  • Aalok Agrawal
  • Director
  • Zeal Shah
  • Company Sec. & Compli. Officer
  • Elizabeth Desmond
  • Director
  • S Madhavan
  • Independent Director
  • Lokesh Chandak
  • Executive Director
  • Seema Sambasivan
  • Non Executive Director

Summary

Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals. The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products. They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs.The company operates in two business divisions, namely Pharmaceuticals and Chemicals. The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products. The Chemicals business comprises of Bulk Drugs and Pigments. Segment revenue relating to the Chemicals business consists of bulk drugs, pigments and active pharmaceutical ingredients.Merck Ltd was incorporated in the year 1967 as E Merck (India) Ltd. The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities. The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations.The company started their operations as a manufacturer of... Read More


Reports by Procter & Gamble Health Ltd


Reports by Procter & Gamble Health Ltd

Company FAQ

No Record Found